Big Sky Capital

Big Sky Capital is a Kazakhstan and US-based seed venture fund investing primarily in early-stage software companies, with offices in Almaty and the Bay Area. The firm typically invests $250k-$1M at pre-seed and seed. Healthcare exposure is opportunistic rather than thematic. Best fit: early-stage software founders, especially with a connection to Central Asia or Eastern Europe, building digital health or healthcare software at pre-seed or seed who would benefit from a smaller, accessible check and a useful network bridge between emerging markets and the Bay Area; founders comfortable with a smaller fund where the value-add is geographic network rather than deep domain. Entry path is the Big Sky Capital website (bigskyvc.com) and warm intros through the firm’s portfolio and the Central Asia and Eastern European tech communities. Not a fit for biotech therapeutics, medical devices, life sciences tools, or US-focused later-stage founders. For a Central Asia or Eastern Europe-rooted health-tech founder at pre-seed, this is a relevant niche check; for most US healthcare founders, this is unlikely to be a primary or anchor investor and the fit is loose at best.